Table 2:
Category | Factors | Presence of lamina propria (N=217) | Factors | Presence of lamina propria fibrosis (N=123) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||
OR (95% CI) | P value | aOR (95% CI) | P value | OR (95% CI) | P value | aOR (95% CI) | P value | |||
Demographics | Male | 3.11 (1.74–5.54) | <0.001 | Male | 6.51 (1.46–29.02) | 0.01 | 8.37 (1.23–56.74) | 0.03 | ||
Age | 0.89 (0.83–0.95) | 0.001 | ||||||||
Clinical | Antihistamines | 2.13 (1.21–3.73) | 0.008 | Allergic rhinitis | 2.29 (1.02–5.14) | 0.04 | ||||
Nasal topical steroids | 3.03 (1.62–5.66) | 0.001 | Asthma | 2.35 (1.03–5.35) | 0.04 | |||||
Abdominal pain | 0.36 (0.20–0.64) | 0.001 | Dysphagia | 3.18 (1.22–8.25) | 0.01 | |||||
Endoscopy | Edema | 3.58 (1.68–7.62) | 0.001 | Edema | 6.44 (2.68–15.45) | <0.001 | ||||
Furrows | 3.93 (1.94–7.94) | <0.001 | Exudates | 4.54 (1.71–12.03) | 0.002 | |||||
EREFS | 1.88 (1.34–2.63) | <0.001 | Furrows | 4.90 (2.06–11.64) | <0.001 | |||||
EREFS | 2.00 (1.43–2.79) | <0.001 | ||||||||
Histology | Number of biopsies | 1.25 (1.07–1.46) | 0.004 | Number of biopsies | 1.39 (1.10–1.75) | 0.005 | ||||
PEC | 1.02 (1.01–1.03) | <0.001 | PEC | 1.03 (1.01–1.04) | <0.001 | 1.02 (1.00–1.04) | 0.01 | |||
Activity | Active EoE | 4.47 (1.88-10.63) | 0.001 | 4.23 (1.00-18.13) | 0.05 | Active EoE | 6.68 (1.82-24.44) | 0.004 |
OR: Odds ratio; aOR: adjusted odds ratio; CI: confidence interval; EREFS: endoscopic reference score; PEC: peak eosinophil counts